TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT05756660

Sodium Thiosulfate Otoprotection During Salvage Cisplatin Therapy

Cause of deathStaffing, sites or logistics Automatic label, confidence 0.9, unverified. How labels are made.
“This study will be closing at CCHMC and may be transferred to a principal investigator at another insitutiton.”

The sponsor’s own words in the registry.

Life of this trial

20232024202520262027Registered2023-02-09Started2023-03-01Suspended (as of)2026-10-22

Vital statistics

Status
Suspended
Phase
Early Phase 1
Sponsor
Children's Hospital Medical Center, Cincinnati
Sponsor type
University, hospital or other
Conditions
Ototoxicity, Drug-Induced
Interventions
Sodium Thiosulfate
Participants
33 (planned, not actual)
Sites
1
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.